Despite ongoing challenges, emerging CROs are altering the global pharmaceutical and biotechnology landscape by providing significant value to clients. By deploying an adroit combination of talent-, technology-, and market-driven strategies, many of the astute leaders of small CROs are skillfully staging a formidable campaign to establish profitable niches.
This publication is available for viewing. To send the publication to friends or colleagues, use the 'share' button.